Hambrecht & Quist Capital Management »

Hillevax shares owned by Hambrecht & Quist Capital Management

Quarter-by-quarter ownership of Hillevax (HLVX) shares owned by Hambrecht & Quist Capital Management from 13F filings

Historical chart of Hambrecht & Quist Capital Management investment in Hillevax

Tip: Access up to 7 years of quarterly data

All positions including Hillevax held by Hambrecht & Quist Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hillevax by Hambrecht & Quist Capital Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $464k 27k 17.19

More positions owned by Hambrecht & Quist Capital Management

Amgen Common (AMGN)
Johnson & Johnson Common (JNJ)
Gilead Sciences Common (GILD)
Regeneron Pharmaceuticals Common (REGN)
Vertex Pharmaceuticals Common (VRTX)
Eli Lilly and Company Common (LLY)
Unitedhealth Group Common (UNH)
Merck & Co Common (MRK)
AbbVie Common (ABBV)
Biogen Common (BIIB)
AstraZeneca Sponsored ADR (AZN)
Illumina Common (ILMN)
Abbott Laboratories Common (ABT)
Pfizer Common (PFE)
Thermo Fisher Scientific Common (TMO)

View all positions for Hambrecht & Quist Capital Management

Top funds holding Hillevax

Frazier Life Sciences Management
Deerfield Management Company
T. Rowe Price Investment Management
VR Adviser
Franklin Resources
Carlyle
BlackRock
Vanguard Group
StepStone
Samsara BioCapital
Millennium Management
Citadel Advisors
Geode Capital Management
Qiming U.S. Ventures Management
Deutsche Bank Aktiengesellschaft

View all funds holding Hillevax